A double-blind, placebo-controlled singl
โ
Lisa Templeton; Andrew Barker; Keith Wesnes; David Wilkinson
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 203 KB
๐ 2 views
Benzodiazepine agonists have been shown to reduce cognitive functioning by producing attentional deยฎcits similar to those produced by muscarinic antagonists. It has therefore been postulated that benzodiazepine antagonists may improve cognitive function in patients with Alzheimer's disease by indire